These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 36213324)

  • 81. Orphan nuclear receptor Nurr1 promotes Helicobacter pylori-associated gastric carcinogenesis by directly enhancing CDK4 expression.
    Shang W; Liang X; Li S; Li T; Zheng L; Shao W; Wang Y; Liu F; Ma L; Jia J
    EBioMedicine; 2020 Mar; 53():102672. PubMed ID: 32114387
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Prognostic Significance of PD-1, PD-L1 and CD8 Gene Expression Levels in Gastric Cancer.
    Ito S; Masuda T; Noda M; Hu Q; Shimizu D; Kuroda Y; Eguchi H; Tobo T; Utsunomiya T; Mimori K
    Oncology; 2020; 98(7):501-511. PubMed ID: 32380498
    [TBL] [Abstract][Full Text] [Related]  

  • 83. LEM domain containing 1 promotes proliferation via activating the PI3K/Akt signaling pathway in gastric cancer.
    Li Q; Ge Y; Chen X; Wang L; Xia Y; Xu Z; Li Z; Wang W; Yang L; Zhang D; Xu Z
    J Cell Biochem; 2019 Sep; 120(9):15190-15201. PubMed ID: 31021450
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Suppression of esophageal tumor growth and chemoresistance by directly targeting the PI3K/AKT pathway.
    Li B; Li J; Xu WW; Guan XY; Qin YR; Zhang LY; Law S; Tsao SW; Cheung AL
    Oncotarget; 2014 Nov; 5(22):11576-87. PubMed ID: 25344912
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Calponin 1 increases cancer-associated fibroblasts-mediated matrix stiffness to promote chemoresistance in gastric cancer.
    Lu Y; Jin Z; Hou J; Wu X; Yu Z; Yao L; Pan T; Chang X; Yu B; Li J; Li C; Yan M; Yan C; Zhu Z; Liu B; Su L
    Matrix Biol; 2023 Jan; 115():1-15. PubMed ID: 36423735
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Immune-independent acquired resistance to PD-L1 antibody initiated by PD-L1 upregulation via PI3K/AKT signaling can be reversed by anlotinib.
    Gao Y; Feng Y; Liu S; Zhang Y; Wang J; Qin T; Chen P; Li K
    Cancer Med; 2023 Jul; 12(14):15337-15349. PubMed ID: 37350549
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Down-regulation of miR-543 expression increases the sensitivity of colorectal cancer cells to 5-Fluorouracil through the PTEN/PI3K/AKT pathway.
    Liu G; Zhou J; Dong M
    Biosci Rep; 2019 Mar; 39(3):. PubMed ID: 30842340
    [TBL] [Abstract][Full Text] [Related]  

  • 88. MicroRNA -383-5p restrains the proliferation and migration of breast cancer cells and promotes apoptosis via inhibition of PD-L1.
    Azarbarzin S; Hosseinpour-Feizi MA; Banan Khojasteh SM; Baradaran B; Safaralizadeh R
    Life Sci; 2021 Feb; 267():118939. PubMed ID: 33359245
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Smad4 sensitizes colorectal cancer to 5-fluorouracil through cell cycle arrest by inhibiting the PI3K/Akt/CDC2/survivin cascade.
    Zhang B; Leng C; Wu C; Zhang Z; Dou L; Luo X; Zhang B; Chen X
    Oncol Rep; 2016 Mar; 35(3):1807-15. PubMed ID: 26647806
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Tumor suppressive activity of miR-424-5p in breast cancer cells through targeting PD-L1 and modulating PTEN/PI3K/AKT/mTOR signaling pathway.
    Dastmalchi N; Hosseinpourfeizi MA; Khojasteh SMB; Baradaran B; Safaralizadeh R
    Life Sci; 2020 Oct; 259():118239. PubMed ID: 32784058
    [TBL] [Abstract][Full Text] [Related]  

  • 91. PD-L1 Induces Epithelial-Mesenchymal Transition in Nasopharyngeal Carcinoma Cells Through Activation of the PI3K/AKT Pathway.
    Fei Z; Deng Z; Zhou L; Li K; Xia X; Xie R
    Oncol Res; 2019 Jul; 27(7):801-807. PubMed ID: 30982497
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Loss of Smad4 in colorectal cancer induces resistance to 5-fluorouracil through activating Akt pathway.
    Zhang B; Zhang B; Chen X; Bae S; Singh K; Washington MK; Datta PK
    Br J Cancer; 2014 Feb; 110(4):946-57. PubMed ID: 24384683
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Gastric cancer mesenchymal stem cells derived IL-8 induces PD-L1 expression in gastric cancer cells via STAT3/mTOR-c-Myc signal axis.
    Sun L; Wang Q; Chen B; Zhao Y; Shen B; Wang H; Xu J; Zhu M; Zhao X; Xu C; Chen Z; Wang M; Xu W; Zhu W
    Cell Death Dis; 2018 Sep; 9(9):928. PubMed ID: 30206229
    [TBL] [Abstract][Full Text] [Related]  

  • 94. B7-H3 confers stemness characteristics to gastric cancer cells by promoting glutathione metabolism through AKT/pAKT/Nrf2 pathway.
    Xia L; Chen Y; Li J; Wang J; Shen K; Zhao A; Jin H; Zhang G; Xi Q; Xia S; Shi T; Li R
    Chin Med J (Engl); 2023 Aug; 136(16):1977-1989. PubMed ID: 37488673
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Heterophyllin B inhibits the malignant phenotypes of gastric cancer cells via CXCR4.
    Wei Y; Yin L; Zhang J; Tang J; Yu X; Wu Z; Gao Y
    Hum Cell; 2023 Mar; 36(2):676-688. PubMed ID: 36539682
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Circular CPM promotes chemoresistance of gastric cancer via activating PRKAA2-mediated autophagy.
    Fang L; Lv J; Xuan Z; Li B; Li Z; He Z; Li F; Xu J; Wang S; Xia Y; Jiang T; Zhang L; Wang L; Zhang D; Xu H; Yang L; Xu Z; Wang W
    Clin Transl Med; 2022 Jan; 12(1):e708. PubMed ID: 35075806
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Impacts of hyperthermic chemotherapeutic agent on cytotoxicity, chemoresistance-related proteins and PD-L1 expression in human gastric cancer cells.
    Su BC; Chen GY; Yang CM; Chuang WT; Lin MC; Hsu PL; Lee CW; Cheng CC; Wu SY; Pan BS; Yu HH
    Int J Hyperthermia; 2024; 41(1):2310017. PubMed ID: 38350654
    [No Abstract]   [Full Text] [Related]  

  • 98. Evaluation of ITGB1 expression as a predictor of the therapeutic effects of immune checkpoint inhibitors in gastric cancer.
    Xu C; Xie XL; Kang N; Jiang HQ
    BMC Gastroenterol; 2023 Sep; 23(1):298. PubMed ID: 37667169
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Upregulation of CRABP2 by TET1-mediated DNA hydroxymethylation attenuates mitochondrial apoptosis and promotes oxaliplatin resistance in gastric cancer.
    Tang X; Liang Y; Sun G; He Q; Hou Z; Jiang X; Gao P; Qu H
    Cell Death Dis; 2022 Oct; 13(10):848. PubMed ID: 36195596
    [TBL] [Abstract][Full Text] [Related]  

  • 100. A polymorphism in the promoter region of PD-L1 serves as a binding-site for SP1 and is associated with PD-L1 overexpression and increased occurrence of gastric cancer.
    Tao LH; Zhou XR; Li FC; Chen Q; Meng FY; Mao Y; Li R; Hua D; Zhang HJ; Wang WP; Chen WC
    Cancer Immunol Immunother; 2017 Mar; 66(3):309-318. PubMed ID: 27889799
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.